日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient-Reported Outcomes in Metastatic Non-Small-Cell Lung Cancer

转移性非小细胞肺癌患者的身体成分、总生存期、治疗决策和患者报告结局之间的关联

Coletta, Adriana M; Lee, Hyejung; Puri, Sonam; Culleton, Sinead; Covington, Matthew F; Yap, Jeffrey T; Maslana, Kelsey E; Haaland, Benjamin; Akerley, Wallace

Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study.

Linsitinib (OSI-906) 用于治疗成人和儿童野生型胃肠道间质瘤,一项 SARC II 期研究

von Mehren Margaret, George Suzanne, Heinrich Michael C, Schuetze Scott M, Yap Jeffrey T, Yu Jain Q, Abbott Amanda, Litwin Samuel, Crowley John, Belinsky Martin, Janeway Katherine A, Hornick Jason L, Flieder Douglas B, Chugh Rashmi, Rink Lori, Van den Abbeele Annick D

Method for detecting voxelwise changes in fluorodeoxyglucose-positron emission tomography brain images via background adjustment in cancer clinical trials

一种通过背景校正检测氟代脱氧葡萄糖正电子发射断层扫描脑图像中体素级变化的方法,用于癌症临床试验

Qin, Lei; Schwartzman, Armin; McCall, Keisha; Kachouie, Nezamoddin N; Yap, Jeffrey T

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)

拉帕替尼联合曲妥珠单抗治疗人表皮生长因子受体 2 阳性转移性乳腺癌患者的 II 期研究:临床结果和早期 [18F]氟代脱氧葡萄糖正电子发射断层扫描成像的预测价值 (TBCRC 003)

Lin, Nancy U; Guo, Hao; Yap, Jeffrey T; Mayer, Ingrid A; Falkson, Carla I; Hobday, Timothy J; Dees, E Claire; Richardson, Andrea L; Nanda, Rita; Rimawi, Mothaffar F; Ryabin, Nicole; Najita, Julie S; Barry, William T; Arteaga, Carlos L; Wolff, Antonio C; Krop, Ian E; Winer, Eric P; Van den Abbeele, Annick D

FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma

FDG 和 FLT-PET 用于早期评估转移性肾细胞癌患者对每日 37.5 mg 舒尼替尼治疗的反应

Horn, Kevin P; Yap, Jeffrey T; Agarwal, Neeraj; Morton, Kathryn A; Kadrmas, Dan J; Beardmore, Britney; Butterfield, Regan I; Boucher, Kenneth; Hoffman, John M

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer

一项针对去势抵抗性前列腺癌患者的依维莫司联合多西他赛的I期研究

Courtney, Kevin D; Manola, Judith B; Elfiky, Aymen A; Ross, Robert; Oh, William K; Yap, Jeffrey T; Van den Abbeele, Annick D; Ryan, Christopher W; Beer, Tomasz M; Loda, Massimo; Priolo, Carmen; Kantoff, Philip; Taplin, Mary-Ellen

Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials

肿瘤临床试验中 18F-FDG PET/CT 成像的 UPICT 方案概述

Graham, Michael M; Wahl, Richard L; Hoffman, John M; Yap, Jeffrey T; Sunderland, John J; Boellaard, Ronald; Perlman, Eric S; Kinahan, Paul E; Christian, Paul E; Hoekstra, Otto S; Dorfman, Gary S

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

一项针对雌激素受体阳性/人表皮生长因子受体2阴性转移性乳腺癌患者的泛磷脂酰肌醇-3-激酶抑制剂布帕利西布联合来曲唑治疗的Ib期抗癌研究

Mayer, Ingrid A; Abramson, Vandana G; Isakoff, Steven J; Forero, Andres; Balko, Justin M; Kuba, María Gabriela; Sanders, Melinda E; Yap, Jeffrey T; Van den Abbeele, Annick D; Li, Yisheng; Cantley, Lewis C; Winer, Eric; Arteaga, Carlos L

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin

伊马替尼用于治疗发生于黏膜、肢端和慢性日光损伤皮肤的、携带突变激活或扩增的KIT基因的黑色素瘤

Hodi, F Stephen; Corless, Christopher L; Giobbie-Hurder, Anita; Fletcher, Jonathan A; Zhu, Meijun; Marino-Enriquez, Adrian; Friedlander, Philip; Gonzalez, Rene; Weber, Jeffrey S; Gajewski, Thomas F; O'Day, Steven J; Kim, Kevin B; Lawrence, Donald; Flaherty, Keith T; Luke, Jason J; Collichio, Frances A; Ernstoff, Marc S; Heinrich, Michael C; Beadling, Carol; Zukotynski, Katherine A; Yap, Jeffrey T; Van den Abbeele, Annick D; Demetri, George D; Fisher, David E

CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool

CT肿瘤体积测量在晚期非小细胞肺癌中的应用:一种新兴临床工具的性能特征

Nishino, Mizuki; Guo, Mengye; Jackman, David M; DiPiro, Pamela J; Yap, Jeffrey T; Ho, Tak K; Hatabu, Hiroto; Jänne, Pasi A; Van den Abbeele, Annick D; Johnson, Bruce E